Decreased Pulmonary Radiation Resistance of Manganese Superoxide Dismutase (MnSOD)-Deficient Mice is Corrected by Human Manganese Superoxide Dismutase-Plasmid/Liposome (SOD2-PL) Intratracheal Gene Therapy
- 1 October 2000
- journal article
- Published by Radiation Research Society in Radiation Research
- Vol. 154 (4) , 365-374
- https://doi.org/10.1667/0033-7587(2000)154[0365:dprrom]2.0.co;2
Abstract
Epperly, M. W., Epstein, C. J., Travis, E. L. and Greenberger, J. S. Decreased Pulmonary Radiation Resistance of Manganese Superoxide Dismutase (MnSOD)-Deficient Mice is Corrected by Human Manganese Superoxide Dismutase-Plasmid/Liposome (SOD2-PL) Intratracheal Gene Therapy.The pulmonary ionizing radiation sensitivity of C57BL/6 Sod2 /– mice heterozygous for MnSOD deficiency was compared to that Sod2 / control littermates. Embryo fibroblast cell lines from Sod2–/– (neonatal lethal) or Sod2 /– mice produced less biochemically active MnSOD and demonstrated a significantly greater in vitro radiosensitivity. No G2/M-phase cell cycle arrest after 5 Gy was observed in Sod2–/– cells compared to the Sod2 /– or Sod2 / lines. Subclonal Sod2–/– or Sod2 /– embryo fibroblast lines expressing the human SOD2 transgene showed increased biochemical activity of MnSOD and radioresistance. Sod2 /– mice receiving 18 Gy whole-lung irradiation died sooner and had an increased percentage of lung with organizing alveolitis between 100 and 160 days compared to Sod2 / wild-type littermates. Both Sod2 /– and Sod2 / littermates injected intratracheally with human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) complex 24 h prior to whole-lung irradiation showed decreased DNA strand breaks and improved survival with decreased organizing alveolitis. Thus underexpression of MnSOD in the lungs of heterozygous Sod2 /– knockout mice is associated with increased pulmonary radiation sensitivity and parallels increased radiation sensitivity of embryo fibroblast cell lines in vitro. The restoration of cellular radioresistance in vitro and in lungs in vivo by SOD2-PL transgene expression supports a potential role for SOD2-PL gene therapy in organ-specific radioprotection.Keywords
This publication has 32 references indexed in Scilit:
- Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: Modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosisTransplantation and Cellular Therapy, 1999
- Redox Gene Therapy Protects Human IB-3 Lung Epithelial Cells Against Ionizing Radiation-Induced ApoptosisHuman Gene Therapy, 1998
- Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapyGene Therapy, 1998
- Immunohistochemical Localization of Transforming Growth Factor β and Tumor Necrosis Factor α in the Lungs of Fibrosis-Prone and "Non-Fibrosing" Mice during the Latent Period and Early Phase after IrradiationRadiation Research, 1997
- The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice.Journal of Clinical Investigation, 1996
- Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutaseNature Genetics, 1995
- Expression of human catalase in acatalasemic murine SV-B2 cells confers protection from oxidative damageFree Radical Biology & Medicine, 1993
- Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factorCell, 1989
- A Friedman-Type Rank Test for Main Effects in a Two-Factor ANOVAJournal of the American Statistical Association, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958